<DOC>
	<DOCNO>NCT00423319</DOCNO>
	<brief_summary>The purpose study learn whether apixaban prevent blood clot leg ( deep vein thrombosis ) lung ( pulmonary embolism ) sometimes occur hip replacement surgery learn apixaban compare enoxaparin prevent clot . The safety apixaban also study</brief_summary>
	<brief_title>Study Investigational Drug Prevention Thrombosis-related Events Following Hip Replacement Surgery ( ADVANCE-3 )</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<criteria>Key Inclusion Criteria Patients undergo elective unilateral total hip replacement revision least 1 component total hip replacement . Patients willing able undergo bilateral ascend contrast venography Either sex , race , 18 year old Key Exclusion Criteria Known suspect bleed coagulation disorder patient firstdegree relative Known suspected history heparininduced thrombocytopenia Known coagulopathy Active bleeding high risk bleed Brain , spinal , ophthalmologic , major surgery trauma within past 90 day Active hepatobiliary disease Alcohol and/or substance abuse within past year Any condition surgery administration anticoagulant contraindicate Two consecutive blood pressure reading within 15 30 minute supine systolic blood pressure &gt; 180 mm Hg supine diastolic blood pressure &gt; 105 mm Hg Clinically significant laboratory abnormality enrollment visit : Hemoglobin &lt; 10 g/dL Platelet count &lt; 100,000/mm^3 Creatinine clearance &lt; 30 mL/min , estimate method Cockcroft Gault Alanine aminotransferase aspartate aminotransferase &gt; 2*upper limit normal total bilirubin â‰¥ 1.5*1 ( unless alternative causative factor Gilbert 's syndrome identify ) Need ongoing treatment parenteral oral anticoagulant ( eg , subject mechanical valve , warfarin eligible atrial fibrillation ) Current use dextrans fibrinolytics Treatment medication affect coagulation platelet function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Prevention deep vein thrombosis</keyword>
	<keyword>pulmonary embolism total hip replacement surgery</keyword>
</DOC>